Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting Emiliano Angeloni, MD, Giovanni Melina, PhD, Umberto Benedetto, PhD, Simone Refice, MD, Fabio Capuano, MD, Antonino Roscitano, MD, Cosimo Comito, MD, Riccardo Sinatra, MD The Annals of Thoracic Surgery Volume 93, Issue 2, Pages 537-544 (February 2012) DOI: 10.1016/j.athoracsur.2011.10.066 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival after coronary artery bypass grafting stratified for metabolic syndrome (MS) occurrence at Kaplan-Meyer analysis. Dashed line indicates patients with metabolic syndrome, solid line patients without metabolic syndrome. (FU = follow-up.) The Annals of Thoracic Surgery 2012 93, 537-544DOI: (10.1016/j.athoracsur.2011.10.066) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Freedom from major adverse cardiac and cerebrovascular events (MACCE) after coronary artery bypass grafting stratified for metabolic syndrome (MS) occurrence at Kaplan-Meyer analysis. Dashed line indicates patients with metabolic syndrome, solid line patients without metabolic syndrome. (FU = follow-up.) The Annals of Thoracic Surgery 2012 93, 537-544DOI: (10.1016/j.athoracsur.2011.10.066) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions